Search results
Rapport Therapeutics raises up to $154 million in IPO - Boston Business Journal
The Business Journals· 7 hours agoRapport Therapeutics Inc. said late Thursday it has raised $154 million in an initial public offering. Rapport (Nasdaq: RAPP), a Boston-based ...
Telix Announces Launch of Proposed Initial Public Offering in the United States By Investing.com
Investing.com· 2 days agoTelix Pharmaceuticals Limited (the “Company” or “Telix”) today announces the launch of its initial ...
Radiopharma-focused Telix heats up IPO summer market with $200M offering
FierceBiotech· 2 days agoAustralian radiopharmaceuticals biotech Telix Pharmaceuticals is targeting a $200 million initial ...
Illumina to spin off early cancer detection test maker Grail after ill-fated $8 billion acquisition...
The Business Journals· 2 days agoMore than three years after planning its own initial public offering, early cancer detection test...
Life360 IPO: Stock price closely watched today as tracker app and Tile parent lists on Nasdaq
Fast Company Magazine· 1 day agoAnother tech company this week is holding its initial public offering and making its debut on the...
J&J-backed Rapport Therapeutics valued at $636.8 million after shares rise 6% in debut
WHTC 1450 Holland· 2 hours ago(Reuters) - Shares of Rapport Therapeutics, backed by Johnson & Johnson's venture capital arm, rose nearly 6% in their market debut on Friday, valuing the early stage therapy developer at $636.8 ...
Life360 Announces Pricing of U.S. Initial Public Offering
KOIN News 6 Portland· 1 day agoSan Francisco area-based Life360, Inc. ("Life360" or the "Company") today announced the pricing of its initial public offering in the U.S. (the "Offering ...
EQT-Backed Waystar Weighs Pricing IPO Around Mid-Range
Bloomberg via Yahoo Finance· 23 hours ago(Bloomberg) -- Health-care payments software maker Waystar Holding Corp. is considering pricing its ...
Healthcare software firm Waystar raises $968 million in IPO
CNBC· 19 hours agoWaystar, a private equity-owned provider of software that helps hospitals and doctors' practices...
ENDRA Life Sciences sets $8 million stock offering By Investing.com
Investing.com· 3 days agoENDRA Life Sciences Inc. (NASDAQ:NDRA), a developer of Thermo Acoustic Enhanced Ultrasound (TAEUS®),...